Bou-Fakhredin, R.; De Franceschi, L.; Motta, I.; Cappellini, M.D.; Taher, A.T.
Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective. Pharmaceuticals 2022, 15, 753.
https://doi.org/10.3390/ph15060753
AMA Style
Bou-Fakhredin R, De Franceschi L, Motta I, Cappellini MD, Taher AT.
Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective. Pharmaceuticals. 2022; 15(6):753.
https://doi.org/10.3390/ph15060753
Chicago/Turabian Style
Bou-Fakhredin, Rayan, Lucia De Franceschi, Irene Motta, Maria Domenica Cappellini, and Ali T. Taher.
2022. "Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective" Pharmaceuticals 15, no. 6: 753.
https://doi.org/10.3390/ph15060753
APA Style
Bou-Fakhredin, R., De Franceschi, L., Motta, I., Cappellini, M. D., & Taher, A. T.
(2022). Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective. Pharmaceuticals, 15(6), 753.
https://doi.org/10.3390/ph15060753